Atlas Trials

Validation of Digital-PCR Analysis Through Programmed Imatinib Interruption in PCR Negative CML Patients

Clinical trial NCT01578213 · COMPLETED

Trial details

NCT number
NCT01578213
Sponsor
University of Milano Bicocca
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Chronic Myeloid Leukemia
Start date
2011-11-09
Primary completion
2018-11-28
Enrollment
112

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.